You are here

vision loss

Novo Nordisk's Ozempic reportedly linked to vision loss in new study

Yahoo Finance

Mon, 12/16/24 - 11:39 am

Pencils down for Graphite, as gene editing biotech merges into vision-loss-focused Lenz

Fierce Biotech

Wed, 11/15/23 - 11:55 am

Lenz Therapeutics

Annexon reports topline results from Phase II trial of geographic atrophy therapy

Clinical Trials Arena

Thu, 05/25/23 - 08:25 pm

clinical trials

geographic atrophy

Belite Bio hits go on IPO to fund late-phase vision loss clinical trials

Fierce Biotech

Wed, 04/6/22 - 12:13 pm

clinical trials

Editas' gene-editing data has company touting prime time based on early vision improvement signals but questions remain

Fierce Biotech

Wed, 09/29/21 - 11:12 am

Editas Medicine

Novartis sharpens focus on vision-restoring gene therapy with $150M Vedere buyout

Fierce Biotech

Thu, 10/29/20 - 11:59 am

ReNeuron shares clinical data on stem cell vision loss therapy

Fierce Biotech

Mon, 10/14/19 - 09:56 am

Retinitis pigmentosa

Roche’s Lucentis Works To Treat Vision Loss From Diabetes

Bloomberg

Tue, 07/24/12 - 11:19 am

diabetic macular edema